RESEARCH ON THE SAFETY AND ACTIVITY OF MELOXICAM TABLETS FOR CHILDREN

The development of safe and effective anti-inflammatory dosage forms for children is one of the most important areas of modern pharmaceutical science. Among nonsteroidal anti-inflammatory drugs, meloxicam is among the most commonly used substances in clinical practice.

Objective. To study the preclinical toxicity and anti-inflammatory activity of meloxicam tablets for children (coated, prolonged effects, special dose).

Methods and materials: acute toxicity in animals was determined, as well as an assessment of specific pharmacological activity in models of histamine-induced and carrageenan aseptic inflammation.

Study results: The study showed that Meloxicam tablets for children are non-toxic and have greater anti-inflammatory activity than the comparison drug.

The study on the specific activity of Meloxicam 3.75 mg tablets for children + cyanocobalamin 0.002 mg demonstrated their high anti-inflammatory activity in experimental aseptic inflammation models. This indicates an increased anti-inflammatory effect of meloxicam when combined with cyanocobalamin.

Conclusion: the results showed that the anti–inflammatory activity of the studied drug, meloxicam children’s tablets, is higher than that of the comparative drug meloxicam.

1. Oen K., Malleson P.N., Cabral D.A. et al. Early predictors of longterm outcome in patients with JRA: subset-specific correlations. J. Rheumatol., 2003, 30,585-593

2. Flato B., Lien G., Smerdel A. et al. Prognostic factors in juvenile rheumatoid arthritis: a casecontrol study revealing early predictors and outcome after 14,9 years. J. Rheumatol., 2003, 30, 386-393.

3. Hosseinzadeh H., Moallem S., Moshiri M., Sarnavazi M., Etemad L. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice // Arzneimittelforschung. 2012. Vol. 62 (7). Р. 324–329.

4. Magaña-Villa M., Rocha-González H., Fernández del Valle-Laisequilla C., Granados-Soto V. B-vitamin mixture improves the analgesic effect of diclofenac in patients with osteoarthritis: a double blind study // Drug Res (Stuttg). 2013. Vol. 63 (6). Р. 289–292.

5. Asghar W., Jamali F. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review // Inflammopharmacology. 2015 Feb. Vol. 23 (1). Р. 1–16.

6. Chiu C., Low T., Tey Y., Singh V., Shong H. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial // Singapore Med J. 2011. Vol. 52 (12). Р. 868–873.

7. Mibielli M., Geller M., Cohen J. et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study // Curr Med Res Opin. 2009. Vol. 25 (11). Р. 2589–2599.

8. Vetter G., Bruggemann G., Lettko M. Shortening diclofenac therapy by B vitamins. Results of a randomized double-blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, in painful spinal diseases with degenerative changes // Z. Rheumatol. 1988. Vol. 47 (5). Р. 351–362.

9. Airaksinen O., Brox J., Cedraschi C. et al. European guidelines for the management of chronic nonspecific low back pain // Eur Spine J. 2006. Vol. 15 (Suppl. 2). Р. 192–300.

10. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist. 2004;9(5):571-91. doi: 10.1634/theoncologist.9-5-571.

11. Calderon-Ospina C-A, Nava-Mesa MO, Arbelaez Ariza CE. Effect of Combined Diclofenac and B Vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) for Low Back Pain Management: Systematic Review and Meta-analysis. Pain Med. 2020 Apr 1;21(4):766-81. doi: 10.1093/pm/pnz216